南微医学 (688029)
Micro-Tech (Nanjing) Co., Ltd.
K-Line Chart
No K-line data available
Company NameNanwei Medical Technology Co., Ltd.
Listing Date2019-07-22
Issue Price52.45RMB
Registered Capital18784.742210k RMB
Legal RepresentativeLong Xiaohui
Registered AddressNo. 10, Gaoke 3rd Road, High-Tech Development Zone, Nanjing City, Jiangsu Province
IndustryMedical Devices
Main BusinessResearch, development, production, and sales of endoscopic examination and minimally invasive surgical instruments, as well as equipment and consumables required for microwave ablation. Endoscopic diagnostic and therapeutic instruments are widely used in the clinical diagnosis and treatment of digestive and respiratory tract diseases. Tumor ablation equipment and consumables include microwave ablation therapy devices and microwave ablation needles, primarily used for thermal microwave ablation therapy of tumors.
Company ProfileNanwei Medical Technology Co., Ltd. was founded in 2000. The company is primarily engaged in the research, development, manufacturing, and sales of minimally invasive medical devices. Upholding the principle of 'Serving Clinical Practice with Technology and Innovation,' it is committed to providing high-quality products and services to global medical institutions, helping to improve medical standards, reduce patient suffering, and lower healthcare costs worldwide.
After nearly 20 years of innovative development, the company has evolved from a single product line of non-vascular stents to three major technology platforms, and from a domestic market focus to a dual-driven strategy encompassing both domestic and international markets. It has become a leading company in the minimally invasive diagnosis and treatment field with strong scientific research and innovation capabilities, competitive advantages in core products, and rapid performance growth.
The company's scientific research and innovation capabilities have received authoritative recognition. The National Science and Technology Awards are the highest-level national science and technology awards approved by the State Council. The company has twice received the National Science and Technology Progress Award (Second Class), and R&D personnel from its subsidiary have received the National Technology Invention Award (Second Class). It is one of the few enterprises in the industry to have received multiple national-level science and technology awards. Additionally, the company has undertaken three national-level research projects, holds 36 domestic and international invention patents, and has obtained 28 Class III medical device registration certificates and 45 Class II medical device registration certificates.
Stock Details
1. Key Indicators
- Total Shares(W): 18784.74
- Circulating A-Shares(W): 18784.74
- Earnings Per Share(RMB): 2.7200
- Net Assets Per Share(RMB): 21.6769
- Operating Revenue(W RMB): 238054.04
- Total Profit(W RMB): 62662.72
- **Net Profit Attributable to Parent(W RMB) **: 50926.40
- Net Profit Growth Rate(%): 12.90
- Weighted Return on Equity(%): 12.7500
- Operating Cash Flow Per Share(RMB): 2.5420
- Undistributed Profit Per Share(RMB): 10.0780
- Capital Reserve Per Share(RMB): 10.2164
2. Main Business
The main business covers:
- Research and development of minimally invasive medical devices
- Manufacturing of minimally invasive medical devices
- Sales of minimally invasive medical devices, specifically including instruments for endoscopic examination and minimally invasive surgery, as well as equipment and consumables required for microwave ablation.
3. Company Basic Information
- Company Name: Micro-Tech (Nanjing) Co., Ltd.
- Listing Date: 2019-07-22
- Industry: Pharmaceuticals & Healthcare - Medical Devices
- Address: No. 10, Gaoke 3rd Road, High-tech Development Zone, Nanjing, Jiangsu Province
- Website: https://www.micro-tech.com.cn
- Company Profile: Micro-Tech (Nanjing) Co., Ltd. was founded in 2000 and is primarily engaged in the research, development, production, and sales of minimally invasive medical devices. The company was listed on the SSE STAR Market in 2019, focusing on areas such as endoscopic examination and minimally invasive surgical instruments.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| No public data available for Top 10 Circulating Shareholders |
5. Concept Sectors
- Margin Trading & Securities Lending
- High-Performance Stocks
- Heavily Held by Brokerages
- Heavily Held by Social Security Funds
- MSCI Constituent
- Intensively Researched
- SSE 380
- STAR Market Biotech
- STAR 100
Remarks
- Data update date: 2025-11-06
- Data source: Public market information
